PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $486,125 | -57.2% | 15,845 | -43.1% | 0.01% | -61.3% |
Q1 2023 | $1,137,089 | -30.0% | 27,863 | -33.7% | 0.03% | -32.6% |
Q4 2022 | $1,623,357 | +496.8% | 42,045 | +801.9% | 0.05% | +283.3% |
Q2 2022 | $272,000 | +32.7% | 4,662 | +2.8% | 0.01% | 0.0% |
Q4 2019 | $205,000 | -82.9% | 4,533 | -83.5% | 0.01% | -88.9% |
Q2 2019 | $1,196,000 | +133.1% | 27,502 | +104.2% | 0.11% | +200.0% |
Q1 2019 | $513,000 | -53.2% | 13,467 | -47.2% | 0.04% | -47.8% |
Q4 2018 | $1,097,000 | +116.4% | 25,496 | +146.9% | 0.07% | +81.6% |
Q3 2018 | $507,000 | -61.2% | 10,325 | -74.7% | 0.04% | -58.2% |
Q2 2018 | $1,307,000 | +101.1% | 40,765 | +186.2% | 0.09% | +28.2% |
Q4 2017 | $650,000 | +209.5% | 14,246 | +155.1% | 0.07% | +34.0% |
Q3 2017 | $210,000 | -10.3% | 5,584 | +14.0% | 0.05% | -17.2% |
Q2 2017 | $234,000 | -1.3% | 4,900 | -5.8% | 0.06% | +113.3% |
Q1 2017 | $237,000 | -66.7% | 5,200 | -75.0% | 0.03% | -81.1% |
Q3 2016 | $712,000 | -29.1% | 20,800 | +84.1% | 0.16% | +55.9% |
Q1 2015 | $1,004,000 | – | 11,300 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |